Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ABCG2 | Q9UNQ0 | 3/20 | 0.39 |
| ▸ | USP14 | P54578 | 1/20 | 0.34 |
| ▸ | CYP11B2 | P19099 | 4/20 | 0.34 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.34 |
| ▸ | CYP11B1 | P15538 | 3/20 | 0.34 |
| ▸ | TSHR | P16473 | 1/20 | 0.34 |
| ▸ | RECQL | P46063 | 1/20 | 0.34 |
| ▸ | SCARB1 | Q8WTV0 | 1/20 | 0.33 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.32 |
| ▸ | HPGD | P15428 | 2/20 | 0.32 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.32 |
| ▸ | CRHR1 | P34998 | 1/20 | 0.31 |
| ▸ | TDP2 | O95551 | 1/20 | 0.31 |
| ▸ | GRM5 | P41594 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL23487668 | 0.94 | ABCG2 (0.41) | ABCG2ALDH1A1TSHRKDM4EHPGD | |
| SCHEMBL22563378 | 0.91 | CHEK1 (0.40) | ABCG2ALDH1A1TSHRRECQLCRHR1 | |
| SCHEMBL21109648 | 0.90 | USP14 (0.32) | ABCG2USP14CYP11B2ALDH1A1CYP11B1 | |
| SCHEMBL22170313 | 0.90 | CYP11B2 (0.37) | ABCG2USP14CYP11B2ALDH1A1CYP11B1 | |
| SCHEMBL23487784 | 0.88 | ABCG2 (0.45) | ABCG2ALDH1A1TSHRHSD17B10 | |
| SCHEMBL22563686 | 0.88 | NPSR1 (0.34) | ABCG2USP14ALDH1A1RECQLKDM4E | |
| SCHEMBL22563675 | 0.88 | ABCG2 (0.34) | ABCG2 | |
| SCHEMBL22563387 | 0.88 | STS (0.34) | ABCG2CYP11B2ALDH1A1CYP11B1TSHR | |
| SCHEMBL22563382 | 0.86 | ABCG2 (0.40) | ABCG2USP14ALDH1A1KDM4EHPGD | |
| SCHEMBL23487305 | 0.85 | NPSR1 (0.37) | ABCG2ALDH1A1KDM4EHPGD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20210175434-A1 | ORGANIC MOLECULES FOR USE IN ORGANIC OPTOELECTRONIC DEVICES | SAMSUNG DISPLAY CO., LTD. (KR) | 2021-06-10 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210175434-A1 | ORGANIC MOLECULES FOR USE IN ORGANIC OPTOELECTRONIC DEVICES | OR10J3, OR51E2, OCIAD2 | ABCG2 2612/4885USP14 4155/4885CYP11B2 770/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.